Guardant Health Inc

Common Name

Guardant Health

Country

United States

Sector

Healthcare

Industry

Diagnostics & Research

Employees

1,999

Ticker

Exchange

NASDAQ/NGS

Website

guardanthealth.com

Description

Guardant Health Inc. is an innovative biotechnology company specializing in the development and commercialization of precision oncology diagnostics. This company is recognized for its groundbreaking w... Show more

Financial Statements of Guardant Health

Below are the financial statements of Guardant Health, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in thousands of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	525,540^a	1,133,537^a
Short-term marketable debt securities	314,438^a	35,097^a
Accounts receivable, net	110,253^a	88,783^a
Inventory, net	71,083^a	61,948^a
Prepaid expenses and other current assets, net	33,800^a	27,741^a
Total current assets	1,055,114^a	1,347,106^a
Assets	—	—
Restricted cash	104,215^a	150^a
Property and equipment, net	136,813^a	145,096^a
Right-of-use assets, net	142,265^a	157,616^a
Intangible assets, net	6,760^a	8,979^a
Goodwill	3,290^a	3,290^a
Other assets, net	37,152^a	124,184^a
Total assets	1,485,609^a	1,786,421^a
Current liabilities	—	—
Accounts payable	38,551^a	51,741^a
Accrued compensation	83,219^a	72,736^a
Accrued expenses	68,345^a	63,475^a
Deferred revenue	35,468^a	17,965^a
Total current liabilities	225,583^a	205,917^a
Liabilities and stockholders’ equity (deficit)	—	—
Convertible senior notes, net	1,142,547^a	1,139,966^a
Long-term operating lease liabilities	164,292^a	185,848^a
Other long-term liabilities	92,834^a	96,006^a
Total liabilities	1,625,256^a	1,627,737^a
Stockholders’ equity (deficit)	—	—
Preferred stock	0^a	0^a
Common stock	1^a	1^a
Additional paid-in capital	2,443,788^a	2,304,220^a
Accumulated other comprehensive loss	-5,201^a	-3,675^a
Accumulated deficit	-2,578,235^a	-2,141,862^a
Total stockholders’ equity (deficit)	-139,647^a	158,684^a
Total liabilities and stockholders’ equity (deficit)	1,485,609^a	1,786,421^a

Verified Sources Behind Guardant Health’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Guardant Health’s data sources below and access millions more through our Disclosure Search.

a. Guardant Health's 10-K 2024

Trace every data point back to Guardant Health’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Guardant Health Inc

Financial Statements of Guardant Health

Verified Sources Behind Guardant Health’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Charles River Laboratories International Inc

Revvity Inc

Quest Diagnostics Inc

Danaher Corp

Laboratory Corporation of America Holdings

Veracyte Inc